BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 19, 2013
View Archived Issues
Pharmacological disruption of the Gram-negative bacteria protective capsule using a glycomimetic
Read More
Novel molecular classifier for predicting metastatic thymoma progression
Read More
Novel EGFR inhibitors discovered at Astellas Pharma
Read More
Novartis describes new antineoplastic agents
Read More
NMR reveals novel biomarkers of systemic inflammation
Read More
Phase II trial of Adcetris in combination with standard of care for frontline DLBCL commences
Read More
ADXS-HPV receives orphan drug designation for HPV-associated anal cancer
Read More
Chelsea Therapeutics submits additional information on Northera NDA
Read More
Institut Pasteur Korea and DNDi to focus on neglected diseases
Read More
Forest Laboratories and Almirall delay NDA filing for aclidinium/formoterol
Read More
Ultragenyx receives U.K. approval to conduct phase I/II UX-003 trial
Read More
MannKind reports data from two phase II diabetes studies of Afrezza
Read More
Amorfix Life Sciences provides update on ovarian cancer program
Read More
Researchers identify UBE2C as a potential target gene for melanoma
Read More
Theravance launches Vibativ for hospital-acquired and ventilator-associated bacterial pneumonia
Read More
GSK gains European approval for Tyverb-trastuzumab combination
Read More
Patient enrolled in brain tumor vaccine trial at Northwestern Memorial Hospital
Read More
Boehringer Ingelheim confirms full enrollment in phase III interferon-free HCV trials
Read More
TTP-399 demonstrates efficacy in phase II diabetes trial
Read More
Mologen provides update on product pipeline
Read More
FDA grants orphan drug status for Epizyme's EPZ-5676 in acute leukemia with MLL rearrangements
Read More
Jetrea approved for symptomatic vitreomacular adhesion in Canada
Read More
New kinase inhibitors described at Suzhou NeuPharma
Read More
Norgine's Dantrium shown to reduce fatal anesthetic reaction
Read More
Vernalis presents novel Chk1 inhibitors for cancer and autoimmune disorders
Read More
Prosonix completes all clinical procedures in phase II PSX-1002 study in COPD
Read More